New research was presented at AIDS 2012, the 19th International AIDS Conference, from July 22-27 in Washington, DC. The features below highlight just some of the studies that emerged from the conference.…
HIV patients coinfected with hepatitis C virus (HCV) are at risk for significant morbidity and mortality, but the therapeutic pipeline is growing. Provisional guidance has been issued on the use of new HCV protease inhibitors in coinfected patients.